alpha-aminopyridine has been researched along with Impetigo Contagiosa in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 12 (70.59) | 24.3611 |
| 2020's | 5 (29.41) | 2.80 |
| Authors | Studies |
|---|---|
| Albareda López, N; Grimalt, R; Masramon, X; Torrelo, A; Zsolt, I | 1 |
| Eudaley, S | 1 |
| Andriessen, A; Benjamin, LT; Claro, C; Eichenfield, LF; Esposito, SM; Keller, L; Kircik, L; Kwong, PC; McCuaig, C; Schachner, LA | 1 |
| Andriessen, A; Hebert, AA; Hohl, D; Kircik, LH; Kwong, P; Lynde, CW; Oza, V; Schachner, LA; Torrelo, A | 1 |
| Fortina, AB; Galli, L; Novelli, A; Ruggiero, G; Stefani, S | 1 |
| Mishra, AK; Sahu, JK | 1 |
| Canton, R; Chouinard, L; Tarragó, C | 1 |
| Arañó, A; D'Aniello, F; Esquirol, LP; Lachamp, L; Tarragó, C; Zsolt, I | 1 |
| Canton, R; García-Castillo, M; Gargallo-Viola, D; López, Y; Morrissey, I; Tato, M; Vila, J; Zsolt, I | 1 |
| Albareda, N; Alonso, FG; Hebert, AA; Rosen, T; Rosenberg, N; Roth, S; Zsolt, I | 1 |
| Bell, E; Eiland, LS; Wren, C | 1 |
| Albareda, N; Grimalt, R; Hebert, AA; Masramon, X; Rosen, T; Rosenberg, N; Torrelo, A; Zsolt, I | 1 |
| Cantón, R; García-Castillo, M; Hebert, AA; López, Y; Tato, M; Torrelo, A; Vila, J | 1 |
| Andriessen, A; Bhatia, N; Grada, A; Patele, D; Schachner, L | 1 |
| Cepero, AL; Gropper, S; Kruger, D; Santos, B | 1 |
| Albareda, N; Chelius, K; Gani, M; García-Alonso, F; Gropper, S; Kruger, D; Mitha, I; Vahed, Y | 1 |
8 review(s) available for alpha-aminopyridine and Impetigo Contagiosa
| Article | Year |
|---|---|
Ozenoxacin (Xepi) for the Treatment of Impetigo.
Topics: Administration, Topical; Aminopyridines; Anti-Bacterial Agents; Child; Child, Preschool; Humans; Impetigo; Infant; Quinolones | 2020 |
Do Antimicrobial Resistance Patterns Matter? An Algorithm for the Treatment of Patients With Impetigo.
Topics: Aminopyridines; Anti-Bacterial Agents; Antimicrobial Stewardship; Bridged Bicyclo Compounds, Heterocyclic; Critical Pathways; Delphi Technique; Diterpenes; Drug Resistance, Bacterial; Evidence-Based Medicine; Fusidic Acid; Humans; Impetigo; Microbial Sensitivity Tests; Mupirocin; Practice Guidelines as Topic; Quinolones; Skin Cream; Staphylococcus aureus; Streptococcus pyogenes; Systematic Reviews as Topic | 2021 |
Treatment of Impetigo and Antimicrobial Resistance.
Topics: Administration, Cutaneous; Aminopyridines; Anti-Bacterial Agents; Antimicrobial Stewardship; Drug Prescriptions; Drug Resistance, Bacterial; Humans; Impetigo; Microbial Sensitivity Tests; Practice Guidelines as Topic; Quinolones; Staphylococcus aureus; Treatment Outcome | 2021 |
Pediatric impetigo: an expert panel opinion about its main controversies.
Topics: Aminopyridines; Anti-Bacterial Agents; Cellulitis; Child; Humans; Impetigo; Quinolones | 2022 |
Ozenoxacin: A Novel Drug Discovery for the Treatment of Impetigo.
Topics: Aminopyridines; Animals; Anti-Bacterial Agents; Drug Discovery; Drug Interactions; Humans; Impetigo; Quinolones | 2019 |
Ozenoxacin: A Novel Topical Quinolone for Impetigo.
Topics: Administration, Topical; Aminopyridines; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Female; Humans; Impetigo; Male; Methicillin-Resistant Staphylococcus aureus; Quinolones; Staphylococcus aureus; Treatment Outcome | 2018 |
Ozenoxacin: a review of preclinical and clinical efficacy.
Topics: Aminopyridines; Animals; Anti-Bacterial Agents; Child; Drug Resistance, Bacterial; Humans; Impetigo; Quinolones; Staphylococcus aureus; Treatment Outcome | 2019 |
Topical Ozenoxacin Cream 1% for Impetigo: A Review
Topics: Aminopyridines; Anti-Bacterial Agents; Antimicrobial Stewardship; Clinical Decision-Making; Drug Resistance, Bacterial; Humans; Impetigo; Mutation; Patient Selection; Practice Guidelines as Topic; Quinolones; Skin Cream; Staphylococcus aureus; Treatment Outcome | 2019 |
5 trial(s) available for alpha-aminopyridine and Impetigo Contagiosa
| Article | Year |
|---|---|
Ozenoxacin, a New Effective and Safe Topical Treatment for Impetigo in Children and Adolescents.
Topics: Administration, Topical; Adolescent; Aminopyridines; Anti-Bacterial Agents; Child; Humans; Impetigo; Quinolones; Skin Cream; Treatment Outcome | 2020 |
Efficacy and Safety of Ozenoxacin Cream for Treatment of Adult and Pediatric Patients With Impetigo: A Randomized Clinical Trial.
Topics: Adolescent; Adult; Aminopyridines; Anti-Bacterial Agents; Child; Child, Preschool; Double-Blind Method; Drug Resistance, Bacterial; Female; Humans; Impetigo; Infant; Male; Quinolones; Skin Cream; Staphylococcal Infections; Streptococcal Infections; Streptococcus pyogenes; Young Adult | 2018 |
Topical Antibacterial Agent for Treatment of Adult and Pediatric Patients With Impetigo: Pooled Analysis of Phase 3 Clinical Trials.
Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Aminopyridines; Anti-Bacterial Agents; Child; Child, Preschool; Double-Blind Method; Drug Administration Schedule; Europe; Female; Humans; Impetigo; Infant; Male; Middle Aged; Quinolones; Randomized Controlled Trials as Topic; Russia; Severity of Illness Index; South Africa; Treatment Outcome; United States; Young Adult | 2018 |
Systemic bioavailability and safety of twice-daily topical ozenoxacin 1% cream in adults and children with impetigo.
Topics: Administration, Topical; Adolescent; Adult; Aminopyridines; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythema; Female; Humans; Impetigo; Male; Middle Aged; Pruritus; Quinolones; Young Adult | 2014 |
Ozenoxacin 1% cream in the treatment of impetigo: a multicenter, randomized, placebo- and retapamulin-controlled clinical trial.
Topics: Adolescent; Aminopyridines; Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Child; Child, Preschool; Diterpenes; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Impetigo; Male; Ointments; Quinolones | 2014 |
4 other study(ies) available for alpha-aminopyridine and Impetigo Contagiosa
| Article | Year |
|---|---|
A review of the antibacterial activity of ozenoxacin.
Topics: Aminopyridines; Animals; Anti-Bacterial Agents; Child; Disease Models, Animal; Dogs; Humans; Impetigo; Quinolones; Rats; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes | 2018 |
Therapeutic efficacy of ozenoxacin in animal models of dermal infection with Staphylococcus aureus.
Topics: Administration, Topical; Aminopyridines; Animals; Animals, Outbred Strains; Anti-Bacterial Agents; Bridged Bicyclo Compounds, Heterocyclic; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Humans; Impetigo; Mice; Mupirocin; Ointments; Quinolones; Skin Cream; Staphylococcus aureus; Treatment Outcome; Wound Infection | 2018 |
Comparative in vitro antibacterial activity of ozenoxacin against Gram-positive clinical isolates.
Topics: Aminopyridines; Anti-Bacterial Agents; Humans; Impetigo; Levofloxacin; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Quinolones; Staphylococcaceae; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes | 2018 |
Ozenoxacin 1% cream (Xepi) for impetigo.
Topics: Administration, Cutaneous; Aminopyridines; Anti-Bacterial Agents; Humans; Impetigo; Quinolones; Skin Cream | 2019 |